Citation Impact
Citing Papers
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
2003 StandoutScience
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
2003 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
2006 Standout
Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-κBp65-specific siRNA
2007
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
In Vivo Transfer of Interleukin-1 Receptor Antagonist Gene in Osteoarthritic Rabbit Knee Joints
1999
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
2001 Standout
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
2001
In vivo suppression of early experimental osteoarthritis by interleukin‐1 receptor antagonist using gene therapy
1997
Gout-associated uric acid crystals activate the NALP3 inflammasome
2006 StandoutNature
Interleukin-17 Family Members and Inflammation
2004 Standout
Physicochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: The Role of Lipids and pH
1997
Endothelial activation in monosodium urate monohydrate crystal‐induced inflammation. In vitro and in vivo studies on the roles of tumor necrosis factor α and interleukin‐1
1997
Role of interleukin‐1 and tumor necrosis factor α in matrix degradation of human osteoarthritic cartilage
2005
Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus
2007
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the guinea pig
2010 Standout
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005
2005
SXR, a novel steroid and xenobioticsensing nuclear receptor
1998
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Molecular, Biologic, and Pharmacokinetic Properties of Monoclonal Antibodies: Impact of These Parameters on Early Clinical Development
2007
The use of anakinra in juvenile arthritis
2005
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
IL-6 as a keystone cytokine in health and disease
2015 Standout
Cancer nanotechnology: opportunities and challenges
2005 Standout
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
2010 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Cytokines in autoimmunity
1996
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
2000
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Graves' Ophthalmopathy
2010 Standout
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Ankylosing spondylitis
2007 Standout
Inflammatory Bowel Disease
2002 Standout
Caspase Functions in Cell Death and Disease
2013 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin‐1 receptor antagonist, in combination with methotrexate: Results of a twenty‐four–week, multicenter, randomized, double‐blind, placebo‐controlled trial
2002
NF-κB, Inflammation, and Metabolic Disease
2011 Standout
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
1998
Alterations in Gastric Acidity in Patients Infected with Human Immunodeficiency Virus
1995
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Platelets and the immune continuum
2011 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
Interleukin-1 receptor antagonist as therapy for inflammatory disorders
2001
Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody
1998
Etanercept
2002
Pro-and Anti-inflammatory Cytokines in Rheumatoid Arthritis
1997
Clinical pharmacokinetics of TNF antagonists: How do they differ?
2005
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
The Inflammasomes
2010 Standout
The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis
2008
Safety of Tumour Necrosis Factor-?? Antagonists
2004
2‐Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling
2002 StandoutNobel
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
The TNF and TNF Receptor Superfamilies
2001 Standout
The many facets of macrophages in rheumatoid arthritis
2019
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Management of Crohn's Disease in Adults
2009 Standout
Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: Involvement of membrane-associated cytokines
1998
New Drugs for Rheumatoid Arthritis
2004
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence
2016
Genetic and Pharmacologic Disruption of Interleukin-1β Signaling Inhibits Experimental Aortic Aneurysm Formation
2013
Anti-Cytokine Therapy for Rheumatoid Arthritis
2000
Comparison of Five In Vitro Digestion Models To Study the Bioaccessibility of Soil Contaminants
2002 Standout
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
2005 Standout
The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
2004
Interleukin 6 plays a key role in the development of antigen-induced arthritis
1998
Physicochemical properties of the fluoroquinolone antimicrobials. III. Complexation of lomefloxacin with various metal ions and the effect of metal ion complexation on aqueous solubility
1992
Microfabricated Drug Delivery Systems: Concepts to Improve Clinical Benefit
2001
Transport phenomena in nanofluidics
2008 Standout
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Sorption of Veterinary Pharmaceuticals in Soils: A Review
2001 Standout
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
High Levels of IL-17 in Rheumatoid Arthritis Patients: IL-15 Triggers In Vitro IL-17 Production Via Cyclosporin A-Sensitive Mechanism
2000
Animal Models of Arthritis: Relevance to Human Disease
1999
Works of M. E. Lebsack being referenced
Dose‐range and dose‐frequency study of recombinant human interleukin‐1 receptor antagonist in patients with rheumatoid arthritis
1996
Effect of gastric acidity on enoxacin absorption
1992
Enhanced Pirmenol Elimination by Rifampin
1988
The Pharmacokinetics of Etanercept in Healthy Volunteers
2000
Inhibition of enoxacin absorption by antacids or ranitidine
1989